Ledger.Open graph →
SEC Form D · filed September 19, 2014

Syndax Pharmaceuticals Inc

Offering
$5.0M
Sold
$4.9M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WALTHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Richard C. Temme · Woodland Hills, CADirectorLeslie P. Temme · Woodland Hills, CADirectorRonald P. Kirkpatrick · Ponte Verde, FLExecRichard G. Chyette · Livonia, MIDirectorRamkumar Mandalam · San Carlos, CADirectorLowell G. Sears · San Carlos, CADirectorStephen G. Greenberg · New York, NYExec · DirectorGisela G. Schwab · San Carlos, CADirectorAlbert Rabil, Iii · Boca Raton, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗